Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Palonosetron and Ramosetron for PONV in Spine Surgery
NCT02480088Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ramosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yonsei University. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 48 hours. Started Sep 2014; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02480088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02480088.